This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Availability of data and materials
Roberts JA, Paul SK, Akova M et al (2014) DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072–1083. https://doi.org/10.1093/cid/ciu027
Abdulla A, Ewoldt TMJ, Hunfeld NGM et al (2020) The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial. BMC Infect Dis 20:57. https://doi.org/10.1186/s12879-020-4781-x
Roggeveen LF, Fleuren LM, Guo T et al (2019) Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock—rationale and design of a multicenter randomized controlled superiority trial. Trials. https://doi.org/10.1186/s13063-019-3911-5
Hagel S, Fiedler S, Hohn A et al (2019) Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial. Trials 20:330. https://doi.org/10.1186/s13063-019-3437-x
Rybak MJ, Le J, Lodise TP et al (2020) Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 71:1361–1364. https://doi.org/10.1093/cid/ciaa303
Chai MG, Cotta MO, Abdul-Aziz MH, Roberts JA (2020) What are the current approaches to optimising antimicrobial dosing in the intensive care unit? Pharmaceutics 12(7):638
Gutierrez G (2020) Artificial intelligence in the Intensive Care Unit. Crit Care. https://doi.org/10.1186/s13054-020-2785-y
Peiffer-Smadja N, Rawson TM, Ahmad R et al (2020) Machine learning for clinical decision support in infectious diseases: a narrative review of current applications. Clin Microbiol Infect. https://doi.org/10.1016/j.cmi.2019.09.009
Imai S, Takekuma Y, Miyai T, Sugawara M (2020) A new algorithm optimized for initial dose settings of vancomycin using machine learning. Biol Pharm Bull. https://doi.org/10.1248/bpb.b19-00729
Huang X, Yu Z, Wei X et al (2021) Prediction of vancomycin dose on high-dimensional data using machine learning techniques. Expert Rev Clin Pharmacol 14:761–771. https://doi.org/10.1080/17512433.2021.1911642
Yamashita F, Fujita A, Sasa Y et al (2017) An evolutionary search algorithm for covariate models in population pharmacokinetic analysis. J Pharm Sci 106:2407–2411. https://doi.org/10.1016/j.xphs.2017.04.029
Sepúlveda C, Montiel O, Cornejo Bravo JM, Sepúlveda R (2018) Fuzzy evaluation of pharmacokinetic models. Comput Intell Neurosci. https://doi.org/10.1155/2018/1983897
Smith NM, Lenhard JR, Boissonneault KR et al (2020) Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii. Clin Microbiol Infect 26:1207–1213. https://doi.org/10.1016/j.cmi.2020.02.004
Koch G, Pfister M, Daunhawer I et al (2020) Pharmacometrics and machine learning partner to advance clinical data analysis. Clin Pharmacol Ther. https://doi.org/10.1002/cpt.1774
Finlayson SG, Subbaswamy A, Singh K et al (2021) The clinician and dataset shift in artificial intelligence. N Engl J Med 385:283–286. https://doi.org/10.1056/NEJMc2104626
A special thanks goes out to Jarne Verhaeghe for the thought provoking discussions that aided in writing the more philosophical aspects of this manuscript. TDC receives funding from the FWO Junior Research project HEROI2C (Grant No. G085920N), which investigates hybrid machine learning for improved infection management in critically ill patients. JDW is senior clinical investigator, funded by the Research Foundation Flanders (FWO, Ref. 1881020N).
TDC receives funding from the FWO Junior Research project HEROI2C (Grant No. G085920N), which investigates hybrid machine learning for improved infection management in critically ill patients. JDW is senior clinical investigator funded by the Research Foundation Flanders (FWO, Ref. 1881020 N).
Conflicts of interest
JDW has been consultant for Accelerate Diagnostics, Bayer Healthcare, MSD and Pfizer.
All other authors have no conflicting or competing interests to report.
Consent to participate
Consent for publication
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
About this article
Cite this article
De Corte, T., Elbers, P. & De Waele, J. The future of antimicrobial dosing in the ICU: an opportunity for data science. Intensive Care Med 47, 1481–1483 (2021). https://doi.org/10.1007/s00134-021-06549-1